AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Seminars in neurology

Results: 1-25/454

Authors: Pascuzzi, RM
Citation: Rm. Pascuzzi, Mitochondrial disorders - Introduction of John M. Shoffner, SEM NEUROL, 21(3), 2001, pp. 231-231

Authors: Shoffner, JM
Citation: Jm. Shoffner, Mitochondrial disorders - Preface, SEM NEUROL, 21(3), 2001, pp. 233-234

Authors: Shoffner, JM
Citation: Jm. Shoffner, An introduction: Oxidative phosphorylation diseases, SEM NEUROL, 21(3), 2001, pp. 237-250

Authors: DiMauro, S Andreu, AL Musumeci, O Bonilla, E
Citation: S. Dimauro et al., Diseases of oxidative phosphorylation due to mtDNA mutations, SEM NEUROL, 21(3), 2001, pp. 251-260

Authors: Shoubridge, EA
Citation: Ea. Shoubridge, Nuclear gene defects in respiratory chain disorders, SEM NEUROL, 21(3), 2001, pp. 261-267

Authors: Robinson, BH
Citation: Bh. Robinson, Prenatal diagnosis of disorders of energy metabolism, SEM NEUROL, 21(3), 2001, pp. 269-273

Authors: Biousse, V Newman, NJ
Citation: V. Biousse et Nj. Newman, Neuro-ophthalmology of mitochondrial diseases, SEM NEUROL, 21(3), 2001, pp. 275-291

Authors: Sladky, JT
Citation: Jt. Sladky, Histopathological features of peripheral nerve and muscle in mitochondrialdisease, SEM NEUROL, 21(3), 2001, pp. 293-301

Authors: Dougherty, FE
Citation: Fe. Dougherty, Metabolic testing in mitochondrial disease, SEM NEUROL, 21(3), 2001, pp. 303-308

Authors: Gold, DR Cohen, BH
Citation: Dr. Gold et Bh. Cohen, Treatment of mitochondrial cytopathies, SEM NEUROL, 21(3), 2001, pp. 309-325

Authors: Zullo, SJ
Citation: Sj. Zullo, Gene therapy of mitochondrial DNA mutations: A brief, biased history of allotopic expression in mammalian cells, SEM NEUROL, 21(3), 2001, pp. 327-335

Authors: Krawiecki, N
Citation: N. Krawiecki, Ethical issues surrounding the evaluation of oxidative phosphorylation disorders in children, SEM NEUROL, 21(3), 2001, pp. 337-341

Authors: Pascuzzi, RM
Citation: Rm. Pascuzzi, Introduction of Wim Robberecht, SEM NEUROL, 21(2), 2001, pp. 125-125

Authors: Robberecht, W
Citation: W. Robberecht, Motor neuron diseases - Preface, SEM NEUROL, 21(2), 2001, pp. 127-127

Authors: Brown, RH Robberecht, W
Citation: Rh. Brown et W. Robberecht, Amyotrophic lateral sclerosis: Pathogenesis, SEM NEUROL, 21(2), 2001, pp. 131-139

Authors: Eisen, A
Citation: A. Eisen, Clinical electrophysiology of the upper and lower motor neuron in amyotrophic lateral sclerosis, SEM NEUROL, 21(2), 2001, pp. 141-154

Authors: Borasio, GD Miller, RG
Citation: Gd. Borasio et Rg. Miller, Clinical characteristics and management of ALS, SEM NEUROL, 21(2), 2001, pp. 155-166

Authors: Turner, MR Parton, MJ Leigh, PN
Citation: Mr. Turner et al., Clinical trials in ALS: An overview, SEM NEUROL, 21(2), 2001, pp. 167-175

Authors: Verma, A Bradley, WG
Citation: A. Verma et Wg. Bradley, Atypical motor neuron disease and related motor syndromes, SEM NEUROL, 21(2), 2001, pp. 177-187

Authors: Talbot, K Davies, KE
Citation: K. Talbot et Ke. Davies, Spinal muscular atrophy, SEM NEUROL, 21(2), 2001, pp. 189-197

Authors: Fink, JK
Citation: Jk. Fink, Progressive spastic paraparesis: Hereditary spastic paraplegia and its relation to primary and amyotrophic lateral sclerosis, SEM NEUROL, 21(2), 2001, pp. 199-207

Authors: Arevalo, J Wojcieszek, J Conneally, PM
Citation: J. Arevalo et al., Tracing Woody Guthrie and Huntington's disease, SEM NEUROL, 21(2), 2001, pp. 209-223

Authors: Pascuzzi, RM
Citation: Rm. Pascuzzi, Introduction of Nestor Galvez-Jimenez, SEM NEUROL, 21(1), 2001, pp. 1-1

Authors: Galvez-Jimenez, N
Citation: N. Galvez-jimenez, Movement disorders - Preface, SEM NEUROL, 21(1), 2001, pp. 3-5

Authors: Tuite, P Ebbitt, B
Citation: P. Tuite et B. Ebbitt, Dopamine agonists, SEM NEUROL, 21(1), 2001, pp. 9-14
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>